http://starbulletin.com/2001/06/15/news/story11.html#jump
23:08:05 GMT - June 19th, 2001
ZURICH (AFX) - Serono SA said it
will make an announcement at 7.00 am on Friday about its clinical trials
for Rebif, its drug for multiple sclerosis.
A webcast on the topic is planned
for later in the day, Serono said. Rebif has been pitted against Avonex
from Biogen Inc and Betaferon from Schering AG in a head-to-head clinical
trial in the U.S. According to the most recent statements, the trial is
to be completed in July, and results are to be announced sometime in the
third quarter.
If Rebif wins the trial, the U.S.
FDA most likely will approve much broader use of it, said analysts.
Copyright 2001 AFX News